Inflammation & Allergy - Drug Targets (Discontinued)
Title:Editorial
Volume: 11 Issue: 6
Author(s): Kurt S. Zaenker
Affiliation:
Export Options
About this article
Cite this article as:
S. Zaenker Kurt, Editorial, Inflammation & Allergy - Drug Targets (Discontinued) 2012; 11 (6) . https://dx.doi.org/10.2174/187152812803590000
DOI https://dx.doi.org/10.2174/187152812803590000 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
9
Related Articles
-
Gene Silencing Mediated by Small Interfering RNAs in Mammalian Cells
Current Medicinal Chemistry Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis
Current Pharmaceutical Design Cancer-related Fatigue, Inflammation and Thyrotropin-releasing Hormone
Current Aging Science Protein Informatics and Vaccine Development: Cancer Case Study
Current Topics in Medicinal Chemistry The Impact of Self-Assembly in Medicine and Pharmacology
Current Pharmaceutical Analysis Application of Reproductive Hormone Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Drug Delivery Systems for Prevention and Treatment of Osteoporotic Fracture
Current Drug Targets Outcome Measures Following Sonodynamic Photodynamic Therapy – A Case Series
Current Drug Therapy A Review on the Risk of Myocardial Infarction Associated with the NSAID Diclofenac
Cardiovascular & Hematological Disorders-Drug Targets Three Dimensional Molecular Field Analysis of Thiomorpholine Analogs of TACE Inhibitors Using Receptor Based Alignment
Letters in Drug Design & Discovery Nanoparticle Drug Delivery Systems: Recent Patents and Applications in Nanomedicine
Recent Patents on Nanomedicine Organic Cation Transporters: Physiology, Toxicology and Special Focus on Ethidium as a Novel Substrate
Current Drug Metabolism MicroRNA-96 is Downregulated in Sepsis Neonates and Attenuates LPSInduced Inflammatory Response by Inhibiting IL-16 in Monocytes
Combinatorial Chemistry & High Throughput Screening Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma
Current Drug Discovery Technologies The Serum Protein and Lipid Oxidation Marker Levels in Alzheimers Disease and Effects of Cholinesterase Inhibitors and Antipsychotic Drugs Therapy
Current Alzheimer Research Thioredoxin-1 is a Novel and Attractive Therapeutic Approach for Various Diseases Including Cardiovascular Disorders
Cardiovascular & Hematological Disorders-Drug Targets Oral Tolerance in the Treatment of Rheumatoid Arthritis
Current Drug Targets - Inflammation & Allergy Regulatory T Cells in Atopic Dermatitis
Recent Patents on Inflammation & Allergy Drug Discovery From TGF-β to Cancer Therapy
Current Drug Targets Copper Transport Systems are Involved in Multidrug Resistance and Drug Transport
Current Medicinal Chemistry